Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase binding	INHBA SRC CFC1 CFC1B	1.49e-05	27	112	4	GO:0070696
GeneOntologyMolecularFunction	phospholipase binding	SRC LCK PTPN11 SYK	2.99e-05	32	112	4	GO:0043274
GeneOntologyMolecularFunction	receptor serine/threonine kinase binding	INHBA SRC CFC1 CFC1B	4.29e-05	35	112	4	GO:0033612
GeneOntologyMolecularFunction	activin receptor binding	INHBA CFC1 CFC1B	5.98e-05	14	112	3	GO:0070697
GeneOntologyMolecularFunction	phosphotyrosine residue binding	PIK3R3 LCK PTPN11 SYK	1.91e-04	51	112	4	GO:0001784
GeneOntologyMolecularFunction	phospholipase activator activity	SRC LCK NSMAF	2.80e-04	23	112	3	GO:0016004
GeneOntologyMolecularFunction	lipase activator activity	SRC LCK NSMAF	4.55e-04	27	112	3	GO:0060229
GeneOntologyMolecularFunction	phosphoprotein binding	PIK3R3 SRC LCK PTPN11 SYK	5.16e-04	117	112	5	GO:0051219
GeneOntologyMolecularFunction	protein kinase activity	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	5.56e-04	600	112	11	GO:0004672
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	PIK3R3 LCK PTPN11 SYK	6.12e-04	69	112	4	GO:0045309
GeneOntologyMolecularFunction	insulin receptor binding	IRS4 SRC PTPN11	6.25e-04	30	112	3	GO:0005158
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDK9 PRKD2 PLK2 PIK3R3 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	6.30e-04	709	112	12	GO:0016773
GeneOntologyMolecularFunction	nodal binding	CFC1 CFC1B	8.54e-04	8	112	2	GO:0038100
GeneOntologyMolecularFunction	kinase activity	CDK9 PRKD2 PLK2 PIK3R3 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	1.20e-03	764	112	12	GO:0016301
GeneOntologyBiologicalProcess	positive regulation of ovulation	INHBA INHBB	2.87e-05	2	111	2	GO:0060279
GeneOntologyBiologicalProcess	enzyme-linked receptor protein signaling pathway	PRKD2 HTRA1 IRS4 INHBA INHBB PIK3R3 SRC TSG101 LCK TGFB3 PTPN11 SULF2 FARP1 CFC1 SYK CFC1B FGFR2 NPNT	6.07e-05	1186	111	18	GO:0007167
GeneOntologyBiologicalProcess	peptidyl-amino acid modification	PRKD2 PLK2 TTLL9 SRC STK38 TSG101 LCK CHUK PTPN11 LOXL2 SYK PPIL2 STK39 FGFR2 MLST8 HCLS1	6.67e-05	976	111	16	GO:0018193
GeneOntologyBiologicalProcess	regulation of ovulation	INHBA INHBB	8.58e-05	3	111	2	GO:0060278
GeneOntologyBiologicalProcess	response to hypoxia	NDNF INHBA TM9SF4 SRC MECP2 TGFB3 LOXL2 FGFR2 MLST8	1.11e-04	348	111	9	GO:0001666
GeneOntologyBiologicalProcess	response to decreased oxygen levels	NDNF INHBA TM9SF4 SRC MECP2 TGFB3 LOXL2 FGFR2 MLST8	1.56e-04	364	111	9	GO:0036293
GeneOntologyBiologicalProcess	cellular response to Thyroglobulin triiodothyronine	INHBB NCOR1	1.71e-04	4	111	2	GO:1904017
GeneOntologyBiologicalProcess	left lung morphogenesis	CFC1 CFC1B	1.71e-04	4	111	2	GO:0060460
GeneOntologyBiologicalProcess	tissue morphogenesis	PRKD2 INHBA SRC GRSF1 ST14 CHUK TGFB3 CFC1 CFC1B FGFR2 CTSZ CA2 NPNT	1.98e-04	750	111	13	GO:0048729
GeneOntologyBiologicalProcess	positive regulation of transport	PLK2 INHBA INHBB ABCA13 TM9SF4 SRC TSG101 LYAR MECP2 TGFB3 PTPN11 SYTL4 SYK STK39 HCLS1 CA2	2.17e-04	1081	111	16	GO:0051050
GeneOntologyBiologicalProcess	protein autophosphorylation	PRKD2 SRC LCK RAD50 SYK STK39 FGFR2	2.36e-04	228	111	7	GO:0046777
GeneOntologyBiologicalProcess	negative regulation of dendrite extension	OSTN MECP2	2.84e-04	5	111	2	GO:1903860
GeneOntologyBiologicalProcess	negative regulation of follicle-stimulating hormone secretion	INHBA INHBB	2.84e-04	5	111	2	GO:0046882
GeneOntologyBiologicalProcess	left lung development	CFC1 CFC1B	2.84e-04	5	111	2	GO:0060459
GeneOntologyBiologicalProcess	activin receptor signaling pathway	INHBA INHBB CFC1 CFC1B	3.07e-04	60	111	4	GO:0032924
GeneOntologyBiologicalProcess	regulation of nucleotide catabolic process	SRC NCOR1 SLC4A4 MLST8	3.71e-04	63	111	4	GO:0030811
GeneOntologyBiologicalProcess	regulation of purine nucleotide catabolic process	SRC NCOR1 SLC4A4 MLST8	3.71e-04	63	111	4	GO:0033121
GeneOntologyBiologicalProcess	regulation of glycolytic process	SRC NCOR1 SLC4A4 MLST8	3.71e-04	63	111	4	GO:0006110
GeneOntologyBiologicalProcess	ADP catabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	3.80e-04	114	111	5	GO:0046032
GeneOntologyBiologicalProcess	peptidyl-tyrosine phosphorylation	SRC TSG101 LCK PTPN11 SYK FGFR2 MLST8 HCLS1	3.93e-04	327	111	8	GO:0018108
GeneOntologyBiologicalProcess	peptidyl-tyrosine modification	SRC TSG101 LCK PTPN11 SYK FGFR2 MLST8 HCLS1	4.09e-04	329	111	8	GO:0018212
GeneOntologyBiologicalProcess	response to Thyroglobulin triiodothyronine	INHBB NCOR1	4.24e-04	6	111	2	GO:1904016
GeneOntologyBiologicalProcess	negative regulation of apoptotic process in bone marrow cell	PLK2 FGFR2	4.24e-04	6	111	2	GO:0071866
GeneOntologyBiologicalProcess	purine nucleoside diphosphate catabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	4.28e-04	117	111	5	GO:0009137
GeneOntologyBiologicalProcess	purine ribonucleoside diphosphate catabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	4.28e-04	117	111	5	GO:0009181
GeneOntologyBiologicalProcess	positive regulation of bone resorption	SRC SYK CA2	4.50e-04	28	111	3	GO:0045780
GeneOntologyBiologicalProcess	ADP metabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	4.81e-04	120	111	5	GO:0046031
GeneOntologyBiologicalProcess	ribonucleoside diphosphate catabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	4.99e-04	121	111	5	GO:0009191
GeneOntologyBiologicalProcess	positive regulation of glycolytic process	SRC SLC4A4 MLST8	5.01e-04	29	111	3	GO:0045821
GeneOntologyBiologicalProcess	positive regulation of nucleotide catabolic process	SRC SLC4A4 MLST8	5.01e-04	29	111	3	GO:0030813
GeneOntologyBiologicalProcess	positive regulation of purine nucleotide catabolic process	SRC SLC4A4 MLST8	5.01e-04	29	111	3	GO:0033123
GeneOntologyBiologicalProcess	morphogenesis of an epithelium	PRKD2 SRC GRSF1 ST14 CHUK CFC1 CFC1B FGFR2 CTSZ CA2 NPNT	5.10e-04	619	111	11	GO:0002009
GeneOntologyBiologicalProcess	response to oxygen levels	NDNF INHBA TM9SF4 SRC MECP2 TGFB3 LOXL2 FGFR2 MLST8	5.30e-04	430	111	9	GO:0070482
GeneOntologyBiologicalProcess	cellular response to fibroblast growth factor stimulus	NDNF PRKD2 PTPN11 SULF2 FGFR2	5.58e-04	124	111	5	GO:0044344
GeneOntologyBiologicalProcess	nucleoside diphosphate catabolic process	SRC NUDT9 NCOR1 SLC4A4 MLST8	5.58e-04	124	111	5	GO:0009134
GeneOntologyBiologicalProcess	positive regulation of follicle-stimulating hormone secretion	INHBA INHBB	5.92e-04	7	111	2	GO:0046881
GeneOntologyBiologicalProcess	regulation of apoptotic process in bone marrow cell	PLK2 FGFR2	5.92e-04	7	111	2	GO:0071865
GeneOntologyBiologicalProcess	regulation of system process	CDK9 PLK2 INHBA INHBB SRC GRIN2D LCK MECP2 PTPN11 STK39 CTTN NPNT	5.94e-04	734	111	12	GO:0044057
GeneOntologyBiologicalProcess	positive regulation of peptidyl-tyrosine phosphorylation	SRC LCK PTPN11 SYK MLST8 HCLS1	6.23e-04	193	111	6	GO:0050731
MousePheno	eyelids open at birth	PLK2 INHBB CHUK ZNF462 FGFR2	3.28e-05	58	89	5	MP:0001302
MousePheno	abnormal vibrissa follicle morphology	INHBA ST14 CHUK	3.97e-05	11	89	3	MP:0010234
MousePheno	total anomalous pulmonary venous connection, intracardiac	CFC1 CFC1B	4.01e-05	2	89	2	MP:0010443
MousePheno	heart right ventricle hypoplasia	CFC1 CFC1B FGFR2	8.63e-05	14	89	3	MP:0010422
MousePheno	abnormal eyelid morphology	PLK2 INHBB SRC NEB CHUK ZNF462 PTPN11 FGFR2	1.17e-04	233	89	8	MP:0001340
MousePheno	abnormal pectoral muscle morphology	INHBA INHBB	1.20e-04	3	89	2	MP:0003346
Domain	Protein_kinase_ATP_BS	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	1.60e-05	379	111	11	IPR017441
Domain	CORTACTIN	CTTN HCLS1	3.50e-05	2	111	2	PS51090
Domain	Ribosomal_L26	RPL26 RPL26L1	3.50e-05	2	111	2	PF16906
Domain	SPIN-2	SPIN2A SPIN2B	3.50e-05	2	111	2	IPR029564
Domain	HS1_rep	CTTN HCLS1	3.50e-05	2	111	2	PF02218
Domain	Hs1_Cortactin	CTTN HCLS1	3.50e-05	2	111	2	IPR003134
Domain	Ribosomal_L26/L24P_euk/arc	RPL26 RPL26L1	3.50e-05	2	111	2	IPR005756
Domain	PROTEIN_KINASE_ATP	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	9.11e-05	459	111	11	PS00107
Domain	CFC	CFC1 CFC1B	1.05e-04	3	111	2	PF09443
Domain	Ribosomal_L24/26_CS	RPL26 RPL26L1	1.05e-04	3	111	2	IPR005825
Domain	RIBOSOMAL_L24	RPL26 RPL26L1	1.05e-04	3	111	2	PS01108
Domain	Protein_Kinase_C_mu-related	PRKD2 PRKD3	1.05e-04	3	111	2	IPR015727
Domain	Cryptic/Cripto_CFC-dom	CFC1 CFC1B	1.05e-04	3	111	2	IPR019011
Domain	Prot_kinase_dom	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	1.59e-04	489	111	11	IPR000719
Domain	PROTEIN_KINASE_DOM	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	1.70e-04	493	111	11	PS50011
Domain	SH2	PIK3R3 SRC LCK PTPN11 SYK	3.41e-04	101	111	5	PF00017
Domain	SPIN/Ssty	SPIN2A SPIN2B	3.46e-04	5	111	2	IPR003671
Domain	Spin-Ssty	SPIN2A SPIN2B	3.46e-04	5	111	2	PF02513
Domain	Kinase-like_dom	CDK9 PRKD2 PLK2 SRC STK38 LCK CHUK PRKD3 SYK STK39 FGFR2	3.83e-04	542	111	11	IPR011009
Domain	SH2	PIK3R3 SRC LCK PTPN11 SYK	5.05e-04	110	111	5	SM00252
Domain	SH2	PIK3R3 SRC LCK PTPN11 SYK	5.26e-04	111	111	5	PS50001
Domain	SH2	PIK3R3 SRC LCK PTPN11 SYK	5.48e-04	112	111	5	IPR000980
Domain	-	PIK3R3 SRC LCK PTPN11 SYK	5.48e-04	112	111	5	3.30.505.10
Domain	TGFb_propeptide	INHBA INHBB TGFB3	6.01e-04	28	111	3	PF00688
Domain	TGF-b_N	INHBA INHBB TGFB3	6.01e-04	28	111	3	IPR001111
Domain	KOW	RPL26 RPL26L1	7.21e-04	7	111	2	SM00739
Domain	TGF-beta-rel	INHBA INHBB TGFB3	8.94e-04	32	111	3	IPR015615
Domain	TGFb_CS	INHBA INHBB TGFB3	8.94e-04	32	111	3	IPR017948
Domain	DUF3699	GARIN4 GARIN3	1.23e-03	9	111	2	IPR022168
Domain	DUF3699	GARIN4 GARIN3	1.23e-03	9	111	2	PF12480
Domain	TGF-b_C	INHBA INHBB TGFB3	1.37e-03	37	111	3	IPR001839
Domain	TGF_BETA_1	INHBA INHBB TGFB3	1.37e-03	37	111	3	PS00250
Domain	TGFB	INHBA INHBB TGFB3	1.37e-03	37	111	3	SM00204
Domain	TGF_BETA_2	INHBA INHBB TGFB3	1.37e-03	37	111	3	PS51362
Domain	TGF_beta	INHBA INHBB TGFB3	1.37e-03	37	111	3	PF00019
Domain	KOW	RPL26 RPL26L1	1.86e-03	11	111	2	IPR005824
Domain	KOW	RPL26 RPL26L1	1.86e-03	11	111	2	PF00467
Domain	Tyr_kinase_cat_dom	SRC LCK SYK FGFR2	1.88e-03	88	111	4	IPR020635
Domain	TyrKc	SRC LCK SYK FGFR2	1.88e-03	88	111	4	SM00219
Domain	ABC_A	ABCA13 ABCA9	2.22e-03	12	111	2	IPR026082
Domain	Inhibin_asu	INHBA INHBB	2.62e-03	13	111	2	IPR002405
Domain	PROTEIN_KINASE_TYR	SRC LCK SYK FGFR2	2.68e-03	97	111	4	PS00109
Domain	Tyr_kinase_AS	SRC LCK SYK FGFR2	2.68e-03	97	111	4	IPR008266
Domain	SH3_1	SRC LCK NEB CTTN HCLS1	2.98e-03	164	111	5	PF00018
Domain	Translation_prot_SH3-like	RPL26 RPL26L1	4.49e-03	17	111	2	IPR008991
Domain	Rib_L2_dom2	RPL26 RPL26L1	5.03e-03	18	111	2	IPR014722
Domain	-	RPL26 RPL26L1	5.03e-03	18	111	2	2.30.30.30
Domain	Ser/Thr_kinase_AS	CDK9 PRKD2 PLK2 STK38 CHUK PRKD3 STK39	5.47e-03	357	111	7	IPR008271
Domain	S_TKc	CDK9 PRKD2 PLK2 STK38 CHUK PRKD3 STK39	5.63e-03	359	111	7	SM00220
Domain	PROTEIN_KINASE_ST	CDK9 PRKD2 PLK2 STK38 CHUK PRKD3 STK39	5.89e-03	362	111	7	PS00108
Domain	Trypsin_dom	PRSS35 HTRA1 PRSS23 ST14	5.89e-03	121	111	4	IPR001254
Domain	Trypsin	PRSS35 HTRA1 PRSS23 ST14	5.89e-03	121	111	4	PF00089
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY	PRKD2 SRC CHUK PRKD3 PTPN11	2.86e-08	15	91	5	M47816
Pathway	REACTOME_PI3K_AKT_SIGNALING_IN_CANCER	PIK3R3 SRC LCK CHUK PTPN11 FGFR2 MLST8	6.86e-06	110	91	7	M27162
Pathway	REACTOME_PECAM1_INTERACTIONS	SRC LCK PTPN11	5.49e-05	12	91	3	MM14835
Pathway	REACTOME_PECAM1_INTERACTIONS	SRC LCK PTPN11	5.49e-05	12	91	3	M11773
Pathway	REACTOME_CD28_CO_STIMULATION	PIK3R3 SRC LCK MLST8	5.76e-05	33	91	4	M11725
Pathway	REACTOME_CD28_CO_STIMULATION	PIK3R3 SRC LCK MLST8	6.50e-05	34	91	4	MM14992
Pathway	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	PIK3R3 SRC LCK PTPN11 MLST8	6.57e-05	66	91	5	MM14990
Pathway	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	PIK3R3 LCK PTPN11 SYK	7.30e-05	35	91	4	MM14512
Pathway	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	PIK3R3 LCK PTPN11 SYK	7.30e-05	35	91	4	M773
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	PIK3R3 SRC LCK PTPN11	9.12e-05	37	91	4	MM14564
Pathway	PID_FAS_PATHWAY	PIK3R3 SRC CHUK SYK	1.01e-04	38	91	4	M94
Pathway	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	PIK3R3 SRC LCK PTPN11 MLST8	1.14e-04	74	91	5	M17386
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	PIK3R3 SRC LCK PTPN11	1.65e-04	43	91	4	M508
Pathway	PID_NFKAPPAB_ATYPICAL_PATHWAY	SRC LCK SYK	1.66e-04	17	91	3	M26
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	PIK3R3 SRC LCK CHUK ITPR3 PTPN11 USP7 FGFR2 MLST8	1.86e-04	313	91	9	M27867
Pathway	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	EML4 PIK3R3 SRC MIB2 LCK MECP2 CHUK NCOR1 PTPN11 FGFR2 MLST8	1.92e-04	464	91	11	M27547
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER	PIK3R3 SRC LCK PTPN11 FGFR2	1.96e-04	83	91	5	M27163
Pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	PIK3R3 SRC LCK ITPR3 TGFB3 PTPN11 SYTL4 SYK	2.52e-04	257	91	8	MM15454
Pathway	PID_PI3KCI_PATHWAY	PIK3R3 SRC LCK SYK	2.54e-04	48	91	4	M141
Pathway	REACTOME_SIGNALING_BY_KIT_IN_DISEASE	PIK3R3 SRC LCK	2.74e-04	20	91	3	M39002
Pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	PIK3R3 SRC LCK ITPR3 TGFB3 PTPN11 SYTL4 SYK	2.80e-04	261	91	8	M1077
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	SRC LCK PTPN11	3.18e-04	21	91	3	M5876
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	SRC LCK PTPN11	3.18e-04	21	91	3	MM14996
Pathway	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	PIK3R3 LCK MLST8	3.67e-04	22	91	3	M13897
Pathway	WP_B_CELL_RECEPTOR_SIGNALING	LCK CHUK PTPN11 SYK HCLS1	4.05e-04	97	91	5	M39323
Pathway	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	MDH1 SLC4A4 CA2	4.20e-04	23	91	3	M4361
Pathway	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	PIK3R3 LCK MLST8	4.20e-04	23	91	3	MM14993
Pathway	PID_FGF_PATHWAY	SRC PTPN11 FGFR2 CTTN	4.31e-04	55	91	4	M276
Pathway	PID_CXCR4_PATHWAY	PIK3R3 SRC LCK PTPN11 MLST8	4.66e-04	100	91	5	M124
Pathway	PID_FCER1_PATHWAY	CHUK PTPN11 SYK HCLS1	6.01e-04	60	91	4	M7
Pathway	REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES	LCK SYK	6.08e-04	6	91	2	M41736
Pathway	PID_GLYPICAN_1PATHWAY	SRC LCK TGFB3	6.80e-04	27	91	3	M33
Pathway	PID_TCR_PATHWAY	LCK CHUK PTPN11 STK39	7.68e-04	64	91	4	M34
Pathway	REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX	MECP2 NCOR1	8.47e-04	7	91	2	M27899
Pathway	WP_GASTRIN_SIGNALING	PRKD2 PIK3R3 SRC CHUK PTPN11	8.81e-04	115	91	5	M39866
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	PIK3R3 SRC LCK PTPN11 FGFR2	9.89e-04	118	91	5	M713
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PRKD2 IRS4 TSG101 MDH1 LYAR GRSF1 STT3B RAD50 LIG3 PTPN11 RPL26L1 NUP210 USP7 KIF14 DLD CTTN RPL3 VARS1 CA2 FTSJ3	2.79e-08	1425	112	20	30948266
Pubmed	Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.	SRC LCK NEB CTTN HCLS1	2.93e-08	28	112	5	18067320
Pubmed	Expression and localization of the serine proteases high-temperature requirement factor A1, serine protease 23, and serine protease 35 in the mouse ovary.	PRSS35 HTRA1 PRSS23	3.25e-08	3	112	3	18566130
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CDK9 PRKD2 EML4 SRC TTC14 STK38 LCK STT3B CHUK RAD50 PRKD3 USP7 SYK FGFR2 SLC4A4 CTTN	3.87e-08	910	112	16	36736316
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	SRC PTPN11 SYK CTTN HCLS1	4.23e-08	30	112	5	12522270
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RPL26 IRS4 SRSF4 TUT7 ITPR3 RAD50 AHNAK NUP210 USP7 KIF14 DLD RPL3 FTSJ3	1.99e-07	653	112	13	22586326
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	CDK9 SRSF4 LYAR FMNL2 ITPR3 LIG3 FARP1 AHNAK USP7 KIF14 DLD CTTN MITD1	2.24e-07	660	112	13	32780723
Pubmed	Activin promotes differentiation of cultured mouse trophoblast stem cells towards a labyrinth cell fate.	INHBA INHBB CFC1 CFC1B	2.35e-07	17	112	4	19716815
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	INHBB PIK3R3 SRC LCK CHUK PTPN11 SYK FGFR2 CTTN HCLS1	3.65e-07	371	112	10	25241761
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CDK9 SRSF4 STK38 TSG101 LYAR ZC3H6 MECP2 STT3B ZNF462 LIG3 SULF2 FARP1 USP7 PAN2 PPIL2 VARS1	4.00e-07	1082	112	16	38697112
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CDK9 RPL26 TUT7 PRSS23 LYAR MECP2 STT3B ITPR3 RAD50 PLEK2 AHNAK NUP210 USP7 KIF14 CTTN RPL3 FTSJ3	5.80e-07	1257	112	17	36526897
Pubmed	Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.	SRC LCK SYK	6.46e-07	6	112	3	9710204
Pubmed	Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin.	SRC PTPN11 SYK	6.46e-07	6	112	3	15173175
Pubmed	Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors.	SRC LCK PTPN11	6.46e-07	6	112	3	12923167
Pubmed	SPAP2, an Ig family receptor containing both ITIMs and ITAMs.	SRC PTPN11 SYK	6.46e-07	6	112	3	12051764
Pubmed	CoA Synthase is phosphorylated on tyrosines in mammalian cells, interacts with and is dephosphorylated by Shp2PTP.	SRC PTPN11 SYK	6.46e-07	6	112	3	19763791
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	RPL26 IRS4 DCAF8 SRSF4 STK38 MDH1 LYAR RAD50 LIG3 RPL26L1 AHNAK USP7 CTTN RPL3 VARS1 FTSJ3	8.82e-07	1149	112	16	35446349
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	COL6A3 IRS4 ABCA13 NEB CSMD3 CHUK ZNF462 ADAMTS20 RPL3 DSE NSMAF	8.88e-07	513	112	11	25798074
Pubmed	Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.	PIK3R3 SRC LCK SYK	1.03e-06	24	112	4	20624904
Pubmed	SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation.	LCK PTPN11 SYK	1.13e-06	7	112	3	10209036
Pubmed	Effects of TGFbeta2 on wild-type and Tgfbr3 knockout mouse fetal testis.	INHBA INHBB TGFB3	1.13e-06	7	112	3	23303681
Pubmed	Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling.	SRC LCK SYK	1.13e-06	7	112	3	11606584
Pubmed	Endogenous inhibins regulate steroidogenesis in mouse TM3 Leydig cells by altering SMAD2 signalling.	INHBA INHBB TGFB3	1.13e-06	7	112	3	27465829
Pubmed	SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor.	SRC LCK SYK	1.13e-06	7	112	3	10482988
Pubmed	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	CHL1 INHBA INHBB RAD50 NCOR1 LIG3 EXO1	1.39e-06	170	112	7	19064572
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	PRKD2 RPL26 LYAR STT3B ITPR3 MRPL14 RPL26L1 AHNAK USP7 PPIL2 CTTN RPL3 VARS1 FTSJ3	2.33e-06	949	112	14	36574265
Pubmed	In vitro tyrosine phosphorylation of PLC-gamma 1 and PLC-gamma 2 by src-family protein tyrosine kinases.	SRC LCK SYK	2.69e-06	9	112	3	7682059
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CDK9 RPL26 EML4 MDH1 LYAR GRSF1 RAD50 PTPN11 MRPL14 AHNAK USP7 PPIL2 CTTN RPL3 VARS1 CTSZ FTSJ3	2.89e-06	1415	112	17	28515276
Pubmed	Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.	PIK3R3 SRC LCK PTPN11 SYK	3.99e-06	73	112	5	24728074
Pubmed	Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.	PIK3R3 SRC LCK PTPN11 SYK	5.20e-06	77	112	5	22973453
Pubmed	Signaling through the TGF beta-activin receptors ALK4/5/7 regulates testis formation and male germ cell development.	INHBA INHBB TGFB3	7.00e-06	12	112	3	23342175
Pubmed	Phospho-tyrosine dependent protein-protein interaction network.	DCAF8 PIK3R3 SRC ZKSCAN7 LCK EYA3 PTPN11 SYK MLST8	7.59e-06	410	112	9	25814554
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CDK9 SRSF4 TTLL9 LCK LYAR GRSF1 STT3B SYK PPIL2 STK39 MLST8	8.88e-06	653	112	11	33742100
Pubmed	Regulation of the sodium bicarbonate cotransporter kNBC1 function: role of Asp(986), Asp(988) and kNBC1-carbonic anhydrase II binding.	SLC4A4 CA2	1.03e-05	2	112	2	12411514
Pubmed	Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor.	CHUK PTPN11	1.03e-05	2	112	2	11136824
Pubmed	Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence of the oocyte.	INHBA INHBB	1.03e-05	2	112	2	17681301
Pubmed	Elevated expression of activins promotes muscle wasting and cachexia.	INHBA INHBB	1.03e-05	2	112	2	24378873
Pubmed	Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions.	INHBA INHBB	1.03e-05	2	112	2	10932194
Pubmed	Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.	PRKD2 PRKD3	1.03e-05	2	112	2	30841931
Pubmed	Activins are critical modulators of growth and survival.	INHBA INHBB	1.03e-05	2	112	2	14551263
Pubmed	Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell lines.	INHBA INHBB	1.03e-05	2	112	2	21475087
Pubmed	Production of activins by the human endosalpinx.	INHBA INHBB	1.03e-05	2	112	2	12414903
Pubmed	The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.	CFC1 CFC1B	1.03e-05	2	112	2	11174844
Pubmed	A new approach to understanding T cell development: the isolation and characterization of immature CD4-, CD8-, CD3- T cell cDNAs by subtraction cloning.	USP7 PPIL2	1.03e-05	2	112	2	1387565
Pubmed	Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid.	SRC SYK	1.03e-05	2	112	2	22577255
Pubmed	Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.	SRC SYK	1.03e-05	2	112	2	35535424
Pubmed	Protein kinase D3 conditional knockout impairs osteoclast formation and increases trabecular bone volume in male mice.	PRKD2 PRKD3	1.03e-05	2	112	2	37044359
Pubmed	Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions.	SRC TSG101	1.03e-05	2	112	2	20805499
Pubmed	Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets.	SRC SYK	1.03e-05	2	112	2	9389695
Pubmed	Physical and functional association of cortactin with Syk in human leukemic cell line K562.	SYK CTTN	1.03e-05	2	112	2	8636079
Pubmed	Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.	PRKD2 PRKD3	1.03e-05	2	112	2	24840177
Pubmed	Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.	LCK SYK	1.03e-05	2	112	2	16474166
Pubmed	LckBP1, a proline-rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck.	LCK HCLS1	1.03e-05	2	112	2	7628441
Pubmed	The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action.	SRC SYK	1.03e-05	2	112	2	22155395
Pubmed	Molecular mechanism of kNBC1-carbonic anhydrase II interaction in proximal tubule cells.	SLC4A4 CA2	1.03e-05	2	112	2	15218065
Pubmed	Regulation of the Lck SH2 domain by tyrosine phosphorylation.	LCK SYK	1.03e-05	2	112	2	8798764
Pubmed	Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions.	INHBA INHBB	1.03e-05	2	112	2	9226441
Pubmed	Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.	FMNL2 CTTN	1.03e-05	2	112	2	29374558
Pubmed	Identification of the site in the Syk protein tyrosine kinase that binds the SH2 domain of Lck.	LCK SYK	1.03e-05	2	112	2	8798676
Pubmed	Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.	PRKD2 PRKD3	1.03e-05	2	112	2	25802335
Pubmed	The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients.	INHBA INHBB	1.03e-05	2	112	2	34723652
Pubmed	Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.	SRC SYK	1.03e-05	2	112	2	7513017
Pubmed	Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.	PRKD2 PRKD3	1.03e-05	2	112	2	23393329
Pubmed	Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.	SRC PTPN11	1.03e-05	2	112	2	14687660
Pubmed	Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.	CTTN HCLS1	1.03e-05	2	112	2	15710041
Pubmed	Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression.	SPIN2A SPIN2B	1.03e-05	2	112	2	12145692
Pubmed	Phagocytic Receptors Activate Syk and Src Signaling during Borrelia burgdorferi Phagocytosis.	SRC SYK	1.03e-05	2	112	2	28717031
Pubmed	Identification of differentially expressed genes in mouse development using differential display and in situ hybridization.	CFC1 CFC1B	1.03e-05	2	112	2	11327798
Pubmed	Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.	CFC1 CFC1B	1.03e-05	2	112	2	11024280
Pubmed	Effect of human carbonic anhydrase II on the activity of the human electrogenic Na/HCO3 cotransporter NBCe1-A in Xenopus oocytes.	SLC4A4 CA2	1.03e-05	2	112	2	16687407
Pubmed	Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.	INHBA INHBB	1.03e-05	2	112	2	16601134
Pubmed	Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.	SRC LCK	1.03e-05	2	112	2	7685110
Pubmed	Clinical application value of Inhibin B alone or in combination with other hormone indicators in subfertile men with different spermatogenesis status: A study of 324 Chinese men.	INHBA INHBB	1.03e-05	2	112	2	34181290
Pubmed	The identification of novel ovarian proteases through the use of genomic and bioinformatic methodologies.	PRSS35 PRSS23	1.03e-05	2	112	2	16870946
Pubmed	Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.	SRC PTPN11	1.03e-05	2	112	2	23271399
Pubmed	Human and mouse activin genes: Divergent expression of activin A protein variants and identification of a novel heparan sulfate-binding domain in activin B.	INHBA INHBB	1.03e-05	2	112	2	32074129
Pubmed	Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects.	CFC1 CFC1B	1.03e-05	2	112	2	11062482
Pubmed	The Src-cortactin pathway is required for clustering of E-selectin and ICAM-1 in endothelial cells.	SRC CTTN	1.03e-05	2	112	2	12060669
Pubmed	A quantitative protein interaction network for the ErbB receptors using protein microarrays.	IRS4 PIK3R3 SRC PTPN11 SYK	1.12e-05	90	112	5	16273093
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	SRSF4 NEB RAD50 AHNAK USP7 CTTN VARS1	1.13e-05	234	112	7	36243803
Pubmed	Regulation of the ovarian reserve by members of the transforming growth factor beta family.	INHBA INHBB TGFB3	1.15e-05	14	112	3	22847922
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CDK9 PRKD2 RPL26 SRSF4 ZC3H6 ITPR3 NCOR1 LIG3 USP7 DLD PPIL2 CTTN RPL3 VARS1 FTSJ3	1.16e-05	1247	112	15	27684187
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	CHL1 INHBA INHBB CHUK TGFB3 PTPN11 CFC1 FGFR2	1.25e-05	331	112	8	20634891
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL26 HTRA1 SYN3 TSG101 MDH1 FMNL2 MECP2 FARP1 USP7 DLD SLC4A4 ABLIM2 CTTN RPL3 VARS1 CA2	1.43e-05	1431	112	16	37142655
Pubmed	Determinants of trophoblast lineage and cell subtype specification in the mouse placenta.	INHBA INHBB FGFR2	1.44e-05	15	112	3	15963972
Pubmed	Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.	LCK PTPN11 SYK	1.44e-05	15	112	3	10790433
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CDK9 PRKD2 HTRA1 DCAF8 PIK3R3 TSG101 LYAR FMNL2 MECP2 RAD50 SULF2 USP7 STK39 FTSJ3	1.46e-05	1116	112	14	31753913
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL26 IRS4 NEB MECP2 STT3B CHUK PLEK2 NCOR1 RPL26L1 AHNAK DLD CTTN DNAH8 RPL3 VARS1 HCLS1	1.57e-05	1442	112	16	35575683
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	PRKD2 DCAF8 SRSF4 EYA3 STT3B ITPR3 RAD50 PTPN11 NUP210 DLD CTTN RPL3 VARS1	1.59e-05	974	112	13	28675297
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PRKD2 PLK2 DCAF8 VPS26C TSG101 EYA3 MDH1 FMNL2 CHUK USP7 MLST8 CTTN VARS1 MITD1 B4GALT3	1.65e-05	1285	112	15	35914814
Pubmed	Rich, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rac1.	SRC LCK CTTN	1.77e-05	16	112	3	11431473
Pubmed	Developmental changes in extracellular matrix messenger RNAs in the mouse placenta during the second half of pregnancy: possible factors involved in the regulation of placental extracellular matrix expression.	INHBA INHBB TGFB3	1.77e-05	16	112	3	17881772
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL26 SRSF4 ZNF395 LYAR MECP2 STT3B ITPR3 RAD50 NCOR1 LIG3 AHNAK USP7 EXO1 RPL3 FTSJ3	1.79e-05	1294	112	15	30804502
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	RPL26 SRSF4 STK38 RPL26L1 SPIN2A RPL3	1.88e-05	169	112	6	23084401
Pubmed	Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.	PRKD2 IRS4 RAD50 PRKD3 NCOR1 USP7 RPL3	2.13e-05	258	112	7	21081666
Pubmed	Expression of Fgf and Tgfbeta signaling related genes during embryonic endochondral ossification.	INHBA INHBB TGFB3 FGFR2	2.27e-05	51	112	4	15963767
Pubmed	Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition.	INHBA INHBB TGFB3	2.56e-05	18	112	3	9716414
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	IRS4 SRSF4 FMNL2 GRSF1 LIG3 USP7 SYK RPL3 FTSJ3	2.91e-05	486	112	9	30940648
Pubmed	Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.	INHBB CFC1 CFC1B	3.03e-05	19	112	3	28126904
Pubmed	Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.	PRKD2 PRKD3	3.08e-05	3	112	2	26253275
Interaction	RPS19 interactions	CDK9 RPL26 SRSF4 EML4 LYAR MECP2 STT3B PLEK2 RPL26L1 LOXL2 PAN2 KIF14 CTTN RPL3 VARS1 FTSJ3	4.32e-07	639	111	16	int:RPS19
Interaction	CTTN interactions	CDK9 SRC LYAR FMNL2 MECP2 LOXL2 AHNAK USP7 SYK PAN2 KIF14 CTTN CA2	1.19e-06	450	111	13	int:CTTN
Interaction	RRP8 interactions	SRSF4 TUT7 LYAR MECP2 GRSF1 RPL26L1 SYK KIF14 RPL3 FTSJ3	1.71e-06	259	111	10	int:RRP8
Interaction	NOP2 interactions	CDK9 RPL26 TUT7 MECP2 GRSF1 RPL26L1 LOXL2 USP7 KIF14 ZNF431 RPL3 FTSJ3	3.19e-06	416	111	12	int:NOP2
Interaction	PTPN6 interactions	CDK9 RPL26 IRS4 SRSF4 SRC LCK PTPN11 SYK FGFR2 VARS1	3.21e-06	278	111	10	int:PTPN6
Interaction	ZNF354A interactions	RPL26 SRSF4 LYAR MECP2 RPL3	3.35e-06	42	111	5	int:ZNF354A
Interaction	SH3BP2 interactions	SRC LCK SYK CTTN HCLS1	6.56e-06	48	111	5	int:SH3BP2
Interaction	EP300 interactions	CDK9 SRSF4 TTLL9 SRC TSG101 LCK LYAR MECP2 GRSF1 STT3B CHUK RAD50 NCOR1 USP7 SYK KIF14 PPIL2 STK39 MLST8 CTTN VARS1 B4GALT3	6.77e-06	1401	111	22	int:EP300
Interaction	STIP1 interactions	CDK9 IRS4 EML4 LCK EYA3 NEB RAD50 LIG3 TDRD3 PTPN11 FARP1 LOXL2 AHNAK NUP210 USP7 DLD RPL3 VARS1	9.32e-06	1006	111	18	int:STIP1
Interaction	DHX57 interactions	SRSF4 SRC LYAR MECP2 GRSF1 TDRD3 RPL26L1 SYK RPL3	1.08e-05	252	111	9	int:DHX57
Interaction	ACTN4 interactions	CDK9 RPL26 SRC TSG101 NEB PTPN11 LOXL2 AHNAK KIF14 DLD CTTN	1.31e-05	400	111	11	int:ACTN4
Interaction	RSL1D1 interactions	CHL1 RPL26 SRSF4 LYAR GRSF1 CHUK RPL26L1 USP7 KIF14 DLD RPL3 FTSJ3	1.33e-05	479	111	12	int:RSL1D1
Interaction	DDX27 interactions	CDK9 RPL26 SRSF4 LYAR GRSF1 LOXL2 SYK FGFR2 RPL3 FTSJ3	1.41e-05	329	111	10	int:DDX27
Interaction	SIRT7 interactions	CDK9 RPL26 IRS4 SRSF4 TUT7 LYAR ITPR3 RAD50 AHNAK NUP210 USP7 KIF14 DLD RPL3 FTSJ3	1.41e-05	744	111	15	int:SIRT7
Interaction	ANOS1 interactions	NDNF TUT7 RPL26L1 ZNF431 FGFR2 RPL3 FTSJ3	1.43e-05	143	111	7	int:ANOS1
Interaction	RPL10A interactions	CDK9 RPL26 TUT7 LYAR MECP2 GRSF1 RPL26L1 PAN2 KIF14 DLD RPL3 FTSJ3	1.66e-05	490	111	12	int:RPL10A
Interaction	IL6R interactions	PIK3R3 SRC LCK USP7	2.14e-05	30	111	4	int:IL6R
Interaction	RPS15 interactions	CDK9 RPL26 DCAF8 SRSF4 NEB STT3B MRPL14 RPL26L1 SYK KIF14 RPL3	2.21e-05	423	111	11	int:RPS15
Interaction	MECP2 interactions	CDK9 SRSF4 STK38 TSG101 LYAR ZC3H6 MECP2 STT3B ZNF462 NCOR1 LIG3 SULF2 FARP1 RPL26L1 USP7 PAN2 PPIL2 CTTN RPL3 VARS1	2.21e-05	1287	111	20	int:MECP2
Interaction	RPL31 interactions	CDK9 RPL26 DCAF8 TUT7 LYAR STT3B LIG3 RPL26L1 LOXL2 PAN2 KIF14 PPIL2 RPL3 FTSJ3	2.22e-05	680	111	14	int:RPL31
Interaction	FYN interactions	PIK3R3 SRC LCK GRSF1 PTPN11 USP7 SYK KIF14 ANKRD12 FGFR2 VARS1	2.62e-05	431	111	11	int:FYN
Interaction	RPL27 interactions	RPL26 MECP2 CHUK RPL26L1 LOXL2 AHNAK PAN2 KIF14 DLD FGFR2 RPL3	2.62e-05	431	111	11	int:RPL27
Interaction	RPL26L1 interactions	CDK9 RPL26 SRSF4 TUT7 LYAR MECP2 RPL26L1 PAN2 KIF14 RPL3 FTSJ3	2.62e-05	431	111	11	int:RPL26L1
Interaction	IFNAR1 interactions	PRKD2 LCK PTPN11 USP7 FGFR2	2.73e-05	64	111	5	int:IFNAR1
Interaction	ZC3HAV1 interactions	RPL26 SRSF4 LYAR FMNL2 GRSF1 STT3B TDRD3 RPL26L1 USP7 KIF14 DLD RPL3 FTSJ3	2.92e-05	606	111	13	int:ZC3HAV1
Interaction	RPL23A interactions	CDK9 RPL26 LYAR MECP2 GRSF1 RPL26L1 LOXL2 AHNAK PAN2 KIF14 CTTN RPL3 FTSJ3	2.92e-05	606	111	13	int:RPL23A
Interaction	CCT5 interactions	CDK9 DCAF8 TTLL9 MIB2 LCK RAD50 PTPN11 AHNAK PAN2 KIF14 MLST8 NSMAF	3.27e-05	525	111	12	int:CCT5
Interaction	MET interactions	PIK3R3 SRC LCK ST14 PTPN11 NUP210 SYK SLC4A4 CTTN	3.28e-05	290	111	9	int:MET
Interaction	BUD13 interactions	SRSF4 LYAR MECP2 RPL26L1 KIF14 RPL3	3.28e-05	110	111	6	int:BUD13
Interaction	TNIP1 interactions	NDNF PRKD2 RPL26 TSG101 LYAR STT3B ITPR3 LIG3 SULF2 MRPL14 RPL26L1 AHNAK USP7 PPIL2 CTTN RPL3 VARS1 CA2 FTSJ3	3.44e-05	1217	111	19	int:TNIP1
Interaction	DHX8 interactions	RPL26 SRSF4 TTC14 MECP2 RPL26L1 KIF14 PPIL2 RPL3 FTSJ3	3.46e-05	292	111	9	int:DHX8
Interaction	SRP14 interactions	CDK9 MIB2 LYAR MECP2 RPL26L1 LOXL2 PAN2 KIF14 RPL3 FTSJ3	3.50e-05	366	111	10	int:SRP14
Interaction	RPL18A interactions	CDK9 RPL26 TUT7 LYAR GRSF1 RPL26L1 PAN2 KIF14 RPL3 VARS1 FTSJ3	3.65e-05	447	111	11	int:RPL18A
Interaction	DDX21 interactions	CDK9 RPL26 SRSF4 TUT7 LYAR MECP2 GRSF1 RPL26L1 LOXL2 USP7 PAN2 KIF14 RPL3 FTSJ3	4.03e-05	718	111	14	int:DDX21
Interaction	DDX55 interactions	TUT7 MDH1 MECP2 GRSF1 RPL26L1 KIF14 RPL3	4.21e-05	169	111	7	int:DDX55
Interaction	BRIX1 interactions	RPL26 SRSF4 LYAR MECP2 GRSF1 PAN2 KIF14 RPL3 FTSJ3	4.27e-05	300	111	9	int:BRIX1
Interaction	CHMP4B interactions	RPL26 TSG101 PRSS23 LCK LYAR MECP2 ITPR3 MRPL14 FARP1 AHNAK KIF14 CTTN RPL3 MITD1	4.61e-05	727	111	14	int:CHMP4B
Interaction	NONO interactions	CDK9 SRC TSG101 ACYP1 MECP2 RAD50 NUP210 PAN2 KIF14 DLD CTTN CA2	5.04e-05	549	111	12	int:NONO
Interaction	PDGFRA interactions	CDK9 NDNF PIK3R3 PRSS23 PTPN11 SULF2 FARP1 LOXL2 PPIL2 B4GALT3	5.35e-05	385	111	10	int:PDGFRA
Interaction	KIT interactions	PIK3R3 SRC LCK PTPN11 SYK FGFR2	6.72e-05	125	111	6	int:KIT
Interaction	HADHA interactions	SRC MECP2 GRSF1 STT3B PLEK2 FARP1 LOXL2 SYK PAN2 KIF14 FGFR2 VARS1	6.86e-05	567	111	12	int:HADHA
Interaction	SYK interactions	SRC LCK LYAR GRSF1 SYK CTTN HCLS1 FTSJ3	7.58e-05	251	111	8	int:SYK
Interaction	H1-2 interactions	RPL26 DCAF8 ABCA13 TUT7 NEB ZC3H6 RAD50 FARP1 LOXL2 AHNAK KIF14 RPL3 FTSJ3	7.66e-05	666	111	13	int:H1-2
Interaction	CCT7 interactions	DCAF8 TTLL9 MIB2 LCK RAD50 PTPN11 LOXL2 PAN2 KIF14 DLD MLST8 NSMAF	7.84e-05	575	111	12	int:CCT7
Interaction	ADARB1 interactions	RPL26 TUT7 LYAR GRSF1 RAD50 RPL26L1 AHNAK USP7 RPL3 VARS1 FTSJ3	8.18e-05	489	111	11	int:ADARB1
Interaction	INHA interactions	INHBA INHBB USP7	8.64e-05	16	111	3	int:INHA
Interaction	ZNF512 interactions	RPL26 SRSF4 TUT7 LYAR RPL26L1 ZNF431 RPL3 FTSJ3	8.69e-05	256	111	8	int:ZNF512
Interaction	NEK4 interactions	COL6A3 IRS4 DCAF8 ABCA13 NEB CSMD3 CHUK ZNF462 ADAMTS20 RPL3 DSE NSMAF	8.79e-05	582	111	12	int:NEK4
Interaction	OXCT1 interactions	PRSS35 MDH1 PTPN11 AHNAK KIF14 CTTN	9.47e-05	133	111	6	int:OXCT1
Interaction	BAP1 interactions	PRKD2 RPL26 IRS4 DCAF8 SRSF4 STK38 MDH1 LYAR ITPR3 RAD50 LIG3 RPL26L1 AHNAK USP7 EXO1 CTTN RPL3 VARS1 FTSJ3	9.61e-05	1314	111	19	int:BAP1
Interaction	NUPR1 interactions	CDK9 SRSF4 LYAR FMNL2 ITPR3 LIG3 FARP1 AHNAK USP7 KIF14 DLD CTTN MITD1	9.87e-05	683	111	13	int:NUPR1
Interaction	REXO4 interactions	RPL26 SRSF4 LYAR MECP2 GRSF1 RPL26L1 RPL3 FTSJ3	9.94e-05	261	111	8	int:REXO4
Interaction	RPL36 interactions	RPL26 TUT7 MECP2 GRSF1 TDRD3 RPL26L1 LOXL2 PAN2 KIF14 RPL3 FTSJ3	1.07e-04	504	111	11	int:RPL36
Interaction	MAGOH interactions	RPL26 SRSF4 STK38 MECP2 TDRD3 RPL26L1 SPIN2A RPL3	1.08e-04	264	111	8	int:MAGOH
Interaction	DDX24 interactions	CDK9 SRSF4 LYAR CSMD3 MECP2 GRSF1 RPL26L1 USP7 SYK KIF14 RPL3 FTSJ3	1.10e-04	596	111	12	int:DDX24
Interaction	H2AC4 interactions	ZNF395 LYAR LIG3 RPL26L1 LOXL2 USP7 KIF14 DLD VARS1 HCLS1 FTSJ3	1.11e-04	506	111	11	int:H2AC4
Interaction	BIRC3 interactions	PRKD2 IRS4 TSG101 MDH1 LYAR GRSF1 STT3B CHUK RAD50 LIG3 RPL26L1 NUP210 USP7 DLD CTTN RPL3 VARS1 CA2 FTSJ3	1.17e-04	1334	111	19	int:BIRC3
Interaction	EEF1B2 interactions	CDK9 RPL26 LCK AHNAK USP7 DLD RPL3 VARS1	1.19e-04	268	111	8	int:EEF1B2
Interaction	CCDC137 interactions	RPL26 TUT7 LYAR GRSF1 RPL26L1 RPL3 FTSJ3	1.21e-04	200	111	7	int:CCDC137
Interaction	LARP7 interactions	CDK9 RPL26 IRS4 SRSF4 STK38 LCK LYAR GRSF1 MRPL14 RPL26L1 NUP210 KIF14 DLD FGFR2 RPL3 VARS1 FTSJ3	1.22e-04	1113	111	17	int:LARP7
Interaction	RPL18 interactions	CDK9 RPL26 LYAR MECP2 GRSF1 RPL26L1 LOXL2 PAN2 KIF14 RPL3 FTSJ3	1.23e-04	512	111	11	int:RPL18
Interaction	RRS1 interactions	CDK9 SRSF4 LYAR MECP2 GRSF1 SYK KIF14 RPL3 FTSJ3	1.24e-04	345	111	9	int:RRS1
Interaction	CCT3 interactions	CDK9 DCAF8 TTLL9 MIB2 LCK RAD50 LOXL2 PAN2 KIF14 MLST8 VARS1 NSMAF	1.25e-04	604	111	12	int:CCT3
Interaction	INHBB interactions	INHBA INHBB USP7	1.25e-04	18	111	3	int:INHBB
Interaction	CCT4 interactions	CDK9 DCAF8 TTLL9 LCK PTPN11 LOXL2 PAN2 KIF14 MLST8 VARS1 NSMAF	1.29e-04	515	111	11	int:CCT4
Interaction	PLEC interactions	CDK9 MECP2 AHNAK USP7 PAN2 EXO1 KIF14 ABLIM2 CTTN CTSZ	1.33e-04	430	111	10	int:PLEC
Interaction	MYO1B interactions	RPL26 LCK MECP2 LOXL2 USP7 PAN2 KIF14 CTTN	1.36e-04	273	111	8	int:MYO1B
Interaction	MYO5A interactions	CDK9 LCK LOXL2 USP7 PAN2 KIF14 CTTN	1.37e-04	204	111	7	int:MYO5A
Interaction	TAMALIN interactions	SRC PTPN11 SYK	1.48e-04	19	111	3	int:TAMALIN
Interaction	SIT1 interactions	LCK PTPN11 SYK	1.48e-04	19	111	3	int:SIT1
Interaction	SNCA interactions	PLK2 SRSF4 SYN3 SRC STK38 TSG101 RAD50 FARP1 AHNAK USP7 SYK CTTN HCLS1	1.57e-04	716	111	13	int:SNCA
Interaction	CDC42BPA interactions	CDK9 STK38 LCK FMNL2 MECP2 USP7	1.58e-04	146	111	6	int:CDC42BPA
Interaction	FGR interactions	CDK9 SRC SYK KIF14 HCLS1	1.64e-04	93	111	5	int:FGR
Interaction	RPL15 interactions	CDK9 RPL26 TUT7 LCK LYAR MECP2 RPL26L1 PAN2 KIF14 RPL3 FTSJ3	1.66e-04	530	111	11	int:RPL15
Interaction	SUPT16H interactions	CDK9 NEB MECP2 LIG3 LOXL2 USP7 KIF14 DLD FGFR2 SPIN2B	1.67e-04	442	111	10	int:SUPT16H
Interaction	TNFRSF1A interactions	SRC CHUK PTPN11 USP7 SYK KIF14 NSMAF	1.69e-04	211	111	7	int:TNFRSF1A
Interaction	NOC2L interactions	LYAR MECP2 FARP1 RPL26L1 SYK KIF14 RPL3 FTSJ3	1.69e-04	282	111	8	int:NOC2L
Interaction	SHC1 interactions	SRC LCK PTPN11 USP7 SYK KIF14 FGFR2 CTTN VARS1	1.78e-04	362	111	9	int:SHC1
Interaction	SH2D2A interactions	PIK3R3 SRC LCK SYK	1.92e-04	52	111	4	int:SH2D2A
Interaction	PIH1D1 interactions	RPL26 LCK MDH1 LYAR RAD50 PTPN11 FARP1 AHNAK USP7 CTTN RPL3 VARS1 CTSZ	1.93e-04	731	111	13	int:PIH1D1
Interaction	RBM28 interactions	RPL26 SRSF4 STK38 LYAR MECP2 GRSF1 RPL26L1 SYK RPL3	2.01e-04	368	111	9	int:RBM28
Interaction	RBM34 interactions	CDK9 STK38 LYAR GRSF1 RPL26L1 SYK RPL3 FTSJ3	2.05e-04	290	111	8	int:RBM34
Interaction	RRP15 interactions	CDK9 SRSF4 LYAR GRSF1 SYK RPL3	2.35e-04	157	111	6	int:RRP15
Interaction	SART3 interactions	CDK9 RPL26L1 SYK KIF14 CTTN RPL3 VARS1 FTSJ3	2.35e-04	296	111	8	int:SART3
Interaction	EZR interactions	PRKD2 DCAF8 LCK LYAR MECP2 TDRD3 LOXL2 AHNAK SYK KIF14 FTSJ3	2.39e-04	553	111	11	int:EZR
Interaction	ABHD10 interactions	MDH1 MECP2 ZNF462 DLD FGFR2	2.41e-04	101	111	5	int:ABHD10
Interaction	MYBBP1A interactions	RPL26 LYAR MECP2 GRSF1 FARP1 RPL26L1 USP7 KIF14 RPL3 FTSJ3	2.42e-04	463	111	10	int:MYBBP1A
Interaction	EEF1G interactions	RPL26 LCK MECP2 STT3B RPL26L1 USP7 PAN2 KIF14 DLD VARS1	2.42e-04	463	111	10	int:EEF1G
Interaction	LCK interactions	IRS4 SRC STK38 LCK PTPN11 FARP1 USP7 SYK KIF14 VARS1	2.42e-04	463	111	10	int:LCK
Interaction	BCAR1 interactions	RPL26 DCAF8 SRC STK38 TSG101 LCK PTPN11 NUP210 KIF14 FGFR2 MLST8	2.51e-04	556	111	11	int:BCAR1
Interaction	FRS2 interactions	SRC LCK PTPN11 KIF14 FGFR2	2.52e-04	102	111	5	int:FRS2
Interaction	APBA1 interactions	PRKD2 NUDT9 KIF14 PPIL2 MITD1	2.64e-04	103	111	5	int:APBA1
Interaction	TUBG1 interactions	PRKD2 RPL26 IRS4 MECP2 RPL26L1 SYK KIF14 RPL3 FTSJ3	2.65e-04	382	111	9	int:TUBG1
Interaction	SOX2 interactions	RPL26 COL6A3 SRSF4 TUT7 PRSS23 MDH1 LYAR MECP2 GRSF1 STT3B ZNF462 NCOR1 LIG3 USP7 KIF14 CTTN RPL3 MITD1 FTSJ3	2.67e-04	1422	111	19	int:SOX2
Interaction	NAT10 interactions	SRSF4 LYAR MECP2 RPL26L1 LOXL2 USP7 KIF14 RPL3	2.69e-04	302	111	8	int:NAT10
Interaction	RICTOR interactions	RPL26 STK38 LCK CHUK NCOR1 AHNAK KIF14 DLD MLST8 CTTN RPL3 VARS1 CA2	2.78e-04	759	111	13	int:RICTOR
Interaction	DDX56 interactions	CDK9 RPL26 LYAR MECP2 GRSF1 CTTN RPL3 FTSJ3	2.81e-04	304	111	8	int:DDX56
Interaction	RPLP0 interactions	CDK9 RPL26 LYAR MECP2 GRSF1 RPL26L1 LOXL2 USP7 PAN2 KIF14 RPL3 FTSJ3	2.82e-04	660	111	12	int:RPLP0
Interaction	TMPO interactions	CDK9 SRSF4 SRC LCK MECP2 STT3B LIG3 AHNAK USP7 KIF14 DLD RPL3 VARS1	2.88e-04	762	111	13	int:TMPO
Interaction	RPL30 interactions	CDK9 RPL26 LYAR GRSF1 RPL26L1 LOXL2 PAN2 DLD RPL3 FTSJ3	2.92e-04	474	111	10	int:RPL30
Cytoband	Xp11.1	SPIN2A SPIN2B	3.53e-05	4	112	2	Xp11.1
GeneFamily	SH2 domain containing	PIK3R3 SRC LCK PTPN11 SYK	1.01e-04	101	83	5	741
GeneFamily	Proteases, serine	PRSS35 HTRA1 PRSS23 ST14	2.00e-04	63	83	4	738
GeneFamily	Tudor domain containing\|Spindlin family	SPIN2A SPIN2B	2.06e-04	5	83	2	1089
GeneFamily	Tudor domain containing	TDRD3 SPIN2A SPIN2B	6.48e-04	37	83	3	780
GeneFamily	L ribosomal proteins	RPL26 RPL26L1 RPL3	1.66e-03	51	83	3	729
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA9	1.83e-03	14	83	2	805
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	LYAR LIG3	2.10e-03	15	83	2	26
GeneFamily	Exonucleases	PAN2 EXO1	2.40e-03	16	83	2	544
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	EML4 SRC TSG101 EYA3 MECP2 LIG3 ANKRD12 SLC4A4	2.09e-06	198	111	8	M6123
Coexpression	GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN	PRKD2 IRS4 FARP1 AHNAK EXO1 ANKRD12 TRAM2	7.61e-06	168	111	7	M403
Coexpression	GSE14308_TH1_VS_INDUCED_TREG_UP	TTC14 ACYP1 RAD50 TGFB3 TDRD3 PPIL2 ANKRD12	2.36e-05	200	111	7	M3378
Coexpression	MENON_FETAL_KIDNEY_4_PODOCYTES	HTRA1 TTC14 STT3B RAD50 AHNAK ANKRD12 NPNT	2.85e-05	206	111	7	M39254
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	HTRA1 EML4 FMNL2 AHNAK ANKRD12 ABLIM2 NPNT	3.42e-05	212	111	7	M39221
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	PRSS35 COL6A3 MIB2 STT3B TGFB3 DSE	3.49e-05	144	111	6	M335
Coexpression	HU_FETAL_RETINA_FIBROBLAST	NDNF COL6A3 PLK2 EML4 PRSS23 LOXL2 AHNAK FGFR2 DSE	3.92e-05	385	111	9	M39264
Coexpression	PASINI_SUZ12_TARGETS_DN	SELENOW PLK2 PIK3R3 PRSS23 FARP1 LOXL2 AHNAK NPNT	6.15e-05	316	111	8	M2293
Coexpression	PASINI_SUZ12_TARGETS_DN	SELENOW PLK2 PIK3R3 PRSS23 FARP1 LOXL2 AHNAK NPNT	7.17e-05	323	111	8	MM1066
Coexpression	NABA_MATRISOME	NDNF COL6A3 HTRA1 INHBA INHBB ST14 TGFB3 SULF2 LOXL2 CFC1 ADAMTS20 CFC1B CTSZ NPNT	9.27e-05	1008	111	14	MM17056
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZNF395 PTPN11 NUP210 USP7 SYK KIF14 TRAM2	9.65e-05	250	111	7	M11318
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	PLK2 DCAF8 INHBB EML4 PRSS23 MECP2 LOXL2 SPIN2A PAN2 EXO1 TRAM2	9.66e-05	647	111	11	M10351
Coexpression	NABA_MATRISOME	NDNF COL6A3 HTRA1 INHBA INHBB ST14 TGFB3 SULF2 LOXL2 CFC1 ADAMTS20 CFC1B CTSZ NPNT	1.12e-04	1026	111	14	M5889
Coexpression	LEE_BMP2_TARGETS_UP	SELENOW HTRA1 DCAF8 INHBB PIK3R3 ZNF395 PRSS23 ABCA9 ST14 PRKD3 CA2 NPNT	1.18e-04	780	111	12	M2324
Coexpression	NUYTTEN_EZH2_TARGETS_UP	PRSS35 SELENOW PLK2 INHBA ABCA13 ZNF395 MECP2 STT3B TGFB3 PLEK2 STK39 SLC4A4 CTTN DSE	1.20e-04	1033	111	14	M4196
Coexpression	MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL	COL6A3 HTRA1 INHBA TGFB3 SULF2 FARP1 LOXL2 AHNAK TRAM2 HCLS1 DSE	1.51e-04	681	111	11	M39175
Coexpression	LEE_BMP2_TARGETS_UP	SELENOW HTRA1 DCAF8 INHBB PIK3R3 ZNF395 PRSS23 ABCA9 ST14 PRKD3 CA2 NPNT	1.59e-04	805	111	12	MM1067
Coexpression	FOROUTAN_INTEGRATED_TGFB_EMT_UP	COL6A3 HTRA1 INHBA PLEK2 DSE	1.61e-04	120	111	5	M42505
Coexpression	CERVERA_SDHB_TARGETS_1_UP	HTRA1 INHBA PRSS23 LOXL2 ABLIM2	1.61e-04	120	111	5	M15549
Coexpression	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	LYAR ITPR3 ZNF462 PTPN11 MPZL3 ADAMTS20	1.66e-04	191	111	6	M8671
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL3	NDNF HTRA1 INHBB ZNF395 FMNL2 SULF2 AHNAK CFC1 SLC4A4 TRAM2	1.67e-04	574	111	10	M39056
Coexpression	GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	RPL26 SYN3 LCK GRSF1 ITPR3 PRKD3	2.02e-04	198	111	6	M5419
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	CDK9 SELENOW PIK3R3 TSG101 MDH1 LYAR NUDT9 NCOR1 PTPN11 USP7 ANKRD12 RPL3 CTSZ MITD1	2.05e-04	1088	111	14	MM3699
Coexpression	GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	PLK2 PRSS23 TGFB3 SYTL4 AHNAK FGFR2	2.08e-04	199	111	6	M8197
Coexpression	GSE3982_MAST_CELL_VS_DC_DN	TUT7 MDH1 NUDT9 SYK CTTN CA2	2.08e-04	199	111	6	M5427
Coexpression	GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	RPL26 STK38 ZNF395 NCOR1 SYCP2 STK39	2.08e-04	199	111	6	M5414
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	DCAF8 PIK3R3 VPS26C MDH1 ACYP1 MECP2 GRSF1 USP7 DLD	2.12e-04	481	111	9	M3898
Coexpression	GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	TUT7 LCK EYA3 DLD TRAM2 B4GALT3	2.13e-04	200	111	6	M3513
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	DCAF8 VPS26C EYA3 ZC3H6 SYK HACL1	2.13e-04	200	111	6	M8651
Coexpression	GSE30083_SP1_VS_SP4_THYMOCYTE_DN	AHNAK NUP210 ADAMTS20 ANKRD12 DNAH8 DSE	2.13e-04	200	111	6	M5030
Coexpression	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN	INHBA LCK CHUK PTPN11 LOXL2 SYK	2.13e-04	200	111	6	M7751
Coexpression	GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	INHBA TUT7 PRSS23 PTPN11 AHNAK MITD1	2.13e-04	200	111	6	M6480
Coexpression	GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN	PIK3R3 PRSS23 LCK RAD50 GARIN3 PAN2	2.13e-04	200	111	6	M7850
Coexpression	BOYAULT_LIVER_CANCER_SUBCLASS_G2	INHBB PAN2 KIF14	2.24e-04	28	111	3	M10953
Coexpression	KYNG_DNA_DAMAGE_UP	CHL1 EML4 NCOR1 SYK KIF14 HCLS1	2.44e-04	205	111	6	M3961
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PLK2 TM9SF4 STK38 VPS26C LYAR RAD50 PTPN11 AHNAK KIF14 DSE MITD1	2.47e-04	721	111	11	M10237
Coexpression	NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS	HTRA1 ST14 LOXL2	2.76e-04	30	111	3	M47990
Coexpression	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	COL6A3 LIG3 SULF2 STK39	2.79e-04	74	111	4	M13547
Coexpression	NABA_MATRISOME_ASSOCIATED	HTRA1 INHBA INHBB ST14 TGFB3 SULF2 LOXL2 CFC1 ADAMTS20 CFC1B CTSZ	3.02e-04	738	111	11	MM17058
Coexpression	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	PRSS23 LCK SYK	3.05e-04	31	111	3	M12458
Coexpression	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	PLK2 PRSS23 SULF2 LOXL2	3.09e-04	76	111	4	M11825
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_200	HTRA1 ABCA9 NPNT	2.22e-05	11	111	3	gudmap_kidney_adult_RenalCapsule_k2_200
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_100	HTRA1 ABCA9 NPNT	2.96e-05	12	111	3	gudmap_kidney_adult_Podocyte_MafB_k3_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	PRSS35 COL6A3 HTRA1 INHBA PIK3R3 ZNF395 FMNL2 STT3B SULF2 SYTL4 LOXL2 STK39 FGFR2 SLC4A4	3.18e-05	740	111	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3	LCK TGFB3 SULF2 STK39 CA2	3.53e-05	71	111	5	GSM605811_100
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#3	PRSS35 HTRA1 IRS4 PRSS23 ABCA9	3.77e-05	72	111	5	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K3
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	PRSS35 COL6A3 INHBA PIK3R3 ZNF395 FMNL2 TGFB3 SULF2 SYTL4 ZSCAN18 STK39 FGFR2 SLC4A4 DSE	7.08e-05	797	111	14	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	PRSS35 COL6A3 PLK2 HTRA1 INHBA ZNF395 FMNL2 TGFB3 SULF2 SYTL4 LOXL2 STK39 FGFR2 SLC4A4	7.08e-05	797	111	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	PRSS35 PLK2 INHBA PRSS23 FMNL2 STT3B TGFB3 PRKD3 TDRD3 FARP1 LOXL2 ZSCAN18 KIF14 STK39	1.10e-04	831	111	14	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	SYN3 TUT7 TSG101 LYAR FMNL2 MECP2 RAD50 NCOR1 TDRD3 NUP210 EXO1 ADAMTS20 MLST8 CTTN	1.10e-04	831	111	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_500	HTRA1 PRSS23 TGFB3 NPNT	1.70e-04	53	111	4	gudmap_kidney_P0_JuxtaGlom_Ren1_k1_500
CoexpressionAtlas	EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05	PRSS35 NDNF COL6A3 AHNAK CFC1 CFC1B CTSZ NPNT	1.81e-04	300	111	8	PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	PRSS35 COL6A3 HTRA1 INHBA INHBB ZNF395 SULF2 FARP1 LOXL2 EXO1 KIF14 CTTN DSE	1.88e-04	768	111	13	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3	NDNF LCK SULF2 FARP1 AHNAK STK39 DSE NSMAF CA2	2.11e-04	390	111	9	GSM538291_500
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	COL6A3 HTRA1 INHBA PRSS23 ABCA9 TGFB3 SULF2 LOXL2 AHNAK SLC4A4 HCLS1 DSE NPNT	2.13e-04	778	111	13	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000	CHL1 CDK9 PLK2 IRS4 SRC PRSS23 ST14 PLEK2 NCOR1 MPZL3 FGFR2 CA2 NPNT	2.79e-04	800	111	13	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_500	HTRA1 ABCA9 NPNT	2.94e-04	25	111	3	gudmap_kidney_adult_RenalCapsule_k2_500
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_200	HTRA1 PRSS23 ABCA9 TGFB3 SLC4A4 NPNT	3.09e-04	174	111	6	gudmap_kidney_adult_RenalCapsule_200
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200	HTRA1 ABCA9 NPNT	3.71e-04	27	111	3	gudmap_kidney_adult_Podocyte_MafB_k4_200
CoexpressionAtlas	kidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_500	HTRA1 PRSS23 NPNT	3.71e-04	27	111	3	gudmap_kidney_adult_CortVasc_Tie2_k1_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	PRSS35 COL6A3 INHBB FMNL2 STT3B ZNF462 TDRD3 SULF2 FARP1 LOXL2 EXO1 STK39 DSE	3.84e-04	827	111	13	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 HTRA1 ZNF462 FARP1 LOXL2 OSCP1 SLC4A4	5.94e-07	193	112	7	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS35 PLK2 INHBA CSMD3 ABCA9 SULF2 AHNAK	5.94e-07	193	112	7	cd45118ced91b10baed3b1068d4673ec99824b86
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 HTRA1 TGFB3 LOXL2 AHNAK FGFR2 DSE	6.36e-07	195	112	7	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	NS-moderate-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PIK3R3 PRSS23 ST14 FGFR2 SLC4A4 CTTN	6.58e-07	196	112	7	70384c1da9baed843f414cfd1403ddd586a2db07
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 EML4 PIK3R3 PRSS23 STK39 FGFR2 SLC4A4	7.29e-07	199	112	7	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDNF HTRA1 LCK SULF2 AHNAK SPIN2A	3.00e-06	158	112	6	9f0987eaf1766aadb5714b68df7a5d310ea5a57a
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 LCK SULF2 AHNAK SPIN2A STK39	3.85e-06	165	112	6	e24621c8d4dbafb407033d832fe9337f13feae34
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 HTRA1 LCK SULF2 AHNAK STK39	4.13e-06	167	112	6	aef22535a76e93472bcedacbb2c6991f3c9c8cd5
ToppCell	NS-critical-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 ABCA13 PIK3R3 PRSS23 FGFR2 SLC4A4	4.42e-06	169	112	6	aec97583b23112060437b619cb429dc32f29285f
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 HTRA1 INHBA TGFB3 SYCP2 LOXL2	6.98e-06	183	112	6	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 NEB CSMD3 SYCP2 ADAMTS20 SLC4A4	7.20e-06	184	112	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 NEB CSMD3 SYCP2 ADAMTS20 SLC4A4	7.20e-06	184	112	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 NEB CSMD3 SYCP2 ADAMTS20 SLC4A4	7.20e-06	184	112	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS35 COL6A3 HTRA1 TGFB3 LOXL2 FGFR2	8.65e-06	190	112	6	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS35 COL6A3 HTRA1 TGFB3 LOXL2 FGFR2	8.65e-06	190	112	6	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	IPF-Epithelial-Goblet\|Epithelial / Disease state, Lineage and Cell class	CHL1 PLK2 PRSS23 STT3B FGFR2 SLC4A4	8.91e-06	191	112	6	267e1192aaec468c1a59eb24848b37e0e18cbc44
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 HTRA1 PRSS23 ABCA9 SULF2 LOXL2	9.18e-06	192	112	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 HTRA1 PRSS23 ABCA9 TGFB3 SULF2	9.74e-06	194	112	6	ce32e60bcea1b8baf496ce9050832bc8c77d8434
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 HTRA1 PRSS23 ABCA9 TGFB3 SULF2	9.74e-06	194	112	6	a1dc157148885cc8d3685ac81a1f4e3562aeecc9
ToppCell	normal_Lung-T/NK_cells-CD4+_Th\|normal_Lung / Location, Cell class and cell subclass	RPL26 EML4 LCK MPZL3 ANKRD12 RPL3	1.00e-05	195	112	6	d6c69f149f3d96fe83f920e38277dede102d04b5
ToppCell	metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	RPL26 STK38 PRSS23 LYAR AHNAK RPL3	1.00e-05	195	112	6	bff726515ea9ce82c223e6c805000afe2e9b7206
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 INHBA ABCA9 TGFB3 LOXL2 TRAM2	1.00e-05	195	112	6	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	normal_Pleural_Fluid\|World / Location, Cell class and cell subclass	RPL26 LCK LYAR SULF2 RPL3 HCLS1	1.03e-05	196	112	6	7029c9f4a826f6cfdcb5f7a472fba94e8945a771
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	CHL1 ABCA13 PIK3R3 PRSS23 FGFR2 SLC4A4	1.03e-05	196	112	6	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDNF COL6A3 PLK2 INHBB FARP1 LOXL2	1.03e-05	196	112	6	1f47916c2663bd88c1e7c19c6a7688f4c7173ad2
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 COL6A3 HTRA1 TGFB3 LOXL2 NPNT	1.03e-05	196	112	6	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 HTRA1 STT3B TGFB3 SULF2 LOXL2	1.03e-05	196	112	6	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 HTRA1 STT3B TGFB3 SULF2 LOXL2	1.03e-05	196	112	6	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	tumor_Lung-T/NK_cells-CD4+_Th\|tumor_Lung / Location, Cell class and cell subclass	RPL26 EML4 LCK LYAR ANKRD12 RPL3	1.03e-05	196	112	6	42f6441505b6f04321da7953d7fe28088b8bdb89
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF395 FMNL2 ST14 SULF2 SYK CA2	1.06e-05	197	112	6	24bcd56df43796af2833c7ce37719c76dd299c19
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF395 FMNL2 ST14 SULF2 SYK CA2	1.06e-05	197	112	6	ea7dd7f90be34d8e5936c9c8d35e0918ae64433b
ToppCell	severe-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	INHBA ABCA13 ZNF395 NEB ZNF283 EXO1	1.06e-05	197	112	6	70704b149b2820b8601d2495b7cd9cbe91eda262
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 ABCA13 PRSS23 AHNAK STK39 CTTN	1.06e-05	197	112	6	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	PND14-Mesenchymal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 COL6A3 HTRA1 TGFB3 LOXL2 NPNT	1.06e-05	197	112	6	9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	TUT7 LYAR RAD50 SYCP2 AHNAK ANKRD12	1.06e-05	197	112	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 HTRA1 INHBA FARP1 LOXL2 CTSZ	1.09e-05	198	112	6	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-E_(AT2)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	NDNF COL6A3 SELENOW AHNAK CTSZ NPNT	1.09e-05	198	112	6	498f11441c0a0982738537bcfcfc2877866b7400
ToppCell	Healthy_donor\|World / disease group, cell group and cell class (v2)	RPL26 TTC14 PRSS23 LCK AHNAK RPL3	1.09e-05	198	112	6	1ed0b50c9754727a05c27b21f3546bf2e37eef7f
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 COL6A3 HTRA1 TGFB3 FARP1 LOXL2	1.09e-05	198	112	6	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	EML4 MPZL3 AHNAK ANKRD12 DSE CA2	1.09e-05	198	112	6	6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RPL26 EML4 PRSS23 LCK LYAR RPL3	1.09e-05	198	112	6	f77f21f21566a04145217ebf85cd14db48945056
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 ABCA13 PIK3R3 PRSS23 ST14 CTTN	1.09e-05	198	112	6	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	moderate-Epithelial-Secretory\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 ABCA13 PIK3R3 PRSS23 ST14 CTTN	1.09e-05	198	112	6	7d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 HTRA1 INHBA FARP1 LOXL2 CTSZ	1.09e-05	198	112	6	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A3 HTRA1 INHBA FARP1 LOXL2 CTSZ	1.09e-05	198	112	6	196257c4420ac801ed9fbb444f11718adb7560ae
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	COL6A3 INHBA ABCA9 TGFB3 LOXL2 TRAM2	1.09e-05	198	112	6	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	mild-Lymphocytic-CD8_T_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL26 PRSS23 LCK LYAR AHNAK RPL3	1.09e-05	198	112	6	629a1229759f3088cafb36f27a3d19d7249aab3a
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL26 EML4 PRSS23 LCK LYAR RPL3	1.09e-05	198	112	6	7f61a9a3d61992c023cc4bc4571a0a7a1a160833
ToppCell	severe-Lymphocytic-CD8_T_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL26 PRSS23 LCK LYAR AHNAK RPL3	1.09e-05	198	112	6	2cd13418396ab2c53b1be96e7795841c2482bfca
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL26 EML4 PRSS23 LCK LYAR RPL3	1.09e-05	198	112	6	d3d117dc3c2a533365bd2d1a6ab0c60e976d2c10
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RPL26 EML4 PRSS23 LCK LYAR RPL3	1.09e-05	198	112	6	ed39ac9d4b1f50e9086ace3ad3325db0d5f4c323
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_small-bowel / Manually curated celltypes from each tissue	RPL26 EML4 MPZL3 AHNAK ANKRD12 CA2	1.13e-05	199	112	6	508a6efc11b1b45899a968888865731088cac668
ToppCell	Transverse-T_cell\|Transverse / Region, Cell class and subclass	RPL26 EML4 LCK LYAR MPZL3 RPL3	1.13e-05	199	112	6	d33dae977d168d07c004ccfa9da4f6e5c670734a
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 EML4 PIK3R3 PRSS23 FGFR2 SLC4A4	1.13e-05	199	112	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Transverse-(1)_T_cell\|Transverse / shred on region, Cell_type, and subtype	RPL26 EML4 LCK LYAR MPZL3 RPL3	1.13e-05	199	112	6	3c0bd5e11bc99f1b57034f81a923832207060fb0
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 EML4 PIK3R3 PRSS23 STK39 FGFR2	1.13e-05	199	112	6	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 ABCA13 PRSS23 ST14 AHNAK CTTN	1.16e-05	200	112	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 SELENOW ABCA13 PRSS23 AHNAK CTTN	1.16e-05	200	112	6	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Caecum-(1)_T_cell-(12)_Th1\|Caecum / shred on region, Cell_type, and subtype	RPL26 EML4 LCK LYAR MPZL3 RPL3	1.16e-05	200	112	6	61328a95966191aec378fa4cd2a083734354b03c
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 ABCA13 PRSS23 ST14 AHNAK CTTN	1.16e-05	200	112	6	b68d212159b9d04866ba02ff55c35be247805eec
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_CTL\|COVID-19_Mild / Disease, condition lineage and cell class	RPL26 EML4 PRSS23 LCK LYAR RPL3	1.16e-05	200	112	6	11fd7eca2fa399ec3d7f9556d09e07c886cc9e83
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 ABCA13 PRSS23 ST14 AHNAK CTTN	1.16e-05	200	112	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Caecum-T_cell-Th1\|Caecum / Region, Cell class and subclass	RPL26 EML4 LCK LYAR MPZL3 RPL3	1.16e-05	200	112	6	cfa2e8a6230a8a7b43d2c89fd464cb8b4ca79589
ToppCell	356C-Lymphocytic-ILC-ILC-3\|ILC / Donor, Lineage, Cell class and subclass (all cells)	TUT7 PRSS23 PTPN11 USP7	1.70e-05	61	112	4	d0b33a48ee2faf68b270f9279c630437f3e8b20b
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	COL6A3 HTRA1 INHBA PRSS23	3.47e-05	73	112	4	116259a036373bccaeb77fe3c675741a5ca81c52
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD4_CTL\|Leuk-UTI / Disease, Lineage and Cell Type	ZKSCAN7 PRSS23 LCK LYAR DNAH8	4.40e-05	154	112	5	170a421fd69dba2929568c72e983ae9cfaf2aabc
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYN3 CSMD3 ZNF462 ZSCAN18 NPNT	4.97e-05	158	112	5	6d2709b387945c015faa223c20d22b52a4082140
ToppCell	droplet-Liver-LIVER_NPC-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDNF RPL26 LCK GARIN3 AHNAK	5.12e-05	159	112	5	997963d879e5819683793cddf5e1acff1b81a1b8
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 LCK AHNAK SPIN2A STK39	5.12e-05	159	112	5	94bc6ab248a8f02ccbc0facd24e0c7e9fda687d2
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK TGFB3 SULF2 AHNAK SPIN2A	5.12e-05	159	112	5	d2de9391b00b6c47f5fe28a1bad6da2097107ee0
ToppCell	droplet-Liver-LIVER_NPC\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDNF RPL26 LCK GARIN3 AHNAK	5.12e-05	159	112	5	e4eaa88772835d6b78e1a18a0cec52de51e80339
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK TGFB3 SULF2 AHNAK SPIN2A	5.12e-05	159	112	5	da6b7f8039adc19839d6c090a0b3d68fb6445a79
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST14 SYK KIF14 TRAM2 HCLS1	5.27e-05	160	112	5	94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS23 STT3B GARIN4 EXO1 KIF14	5.93e-05	164	112	5	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS23 STT3B GARIN4 EXO1 KIF14	5.93e-05	164	112	5	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF HTRA1 GARIN4 CTSZ NPNT	6.28e-05	166	112	5	dc443a3327dc8f9a0d808c3c6e06b0834d45f5c2
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SELENOW TUT7 RAD50 AHNAK SYK	6.46e-05	167	112	5	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 HTRA1 LCK SULF2 AHNAK	6.46e-05	167	112	5	92ddabbe55315856d8ea6f8db1560b6d97636bac
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF HTRA1 SULF2 ABLIM2 NPNT	6.65e-05	168	112	5	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF HTRA1 SULF2 ABLIM2 NPNT	6.65e-05	168	112	5	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF HTRA1 SULF2 ABLIM2 NPNT	6.65e-05	168	112	5	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 IRS4 TSG101 ACYP1 CTSZ	6.83e-05	169	112	5	7be742160e3e7e6c8f86b037be4e425f4d4cf663
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 IRS4 TSG101 ACYP1 CTSZ	6.83e-05	169	112	5	4ccf5cfa4fe72d3af056d658460a9ccaa07b01be
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	CHL1 ABCA13 PRSS23 FGFR2 SLC4A4	7.23e-05	171	112	5	3965ced4be6db14265a90673502fceee425837ca
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like\|bone_marrow / Manually curated celltypes from each tissue	PRSS35 EML4 LYAR MPZL3 CA2	7.23e-05	171	112	5	2977cffc146470733b5cfd8a1aa80d9346d4804d
ToppCell	metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	CHL1 PLEK2 ZNF283 CA2 NPNT	7.43e-05	172	112	5	38d17e769fe8eac8b57b820490d4ddd969243ee7
ToppCell	droplet-Marrow-nan-24m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS23 LCK NUDT9 CTTN VARS1	7.63e-05	173	112	5	35dc897e06f905419d44093a92170d2cec35dd51
ToppCell	droplet-Marrow-nan-24m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS23 LCK NUDT9 CTTN VARS1	7.63e-05	173	112	5	37825d0dda028cf677ff6ff16ea58bff75cb25a7
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A3 CSMD3 FARP1 LOXL2	7.84e-05	174	112	5	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 HTRA1 LOXL2 NUP210 KIF14	7.84e-05	174	112	5	7b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	CHL1 PRSS23 SYCP2 FGFR2 SLC4A4	7.84e-05	174	112	5	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK GARIN3 SYTL4 SLC4A4 HCLS1	8.50e-05	177	112	5	7853430fb0d1a18d835e8956777e0616c5d7d412
ToppCell	facs-Skin-Anagen-3m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK GARIN3 SYTL4 SLC4A4 HCLS1	8.50e-05	177	112	5	395f005f019aabb18738d3a10a04c37f216deda3
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK GARIN3 SYTL4 SLC4A4 HCLS1	8.50e-05	177	112	5	9a5bf67a801826d094f679dd2189b62296c9694f
ToppCell	lung\|World / shred on tissue and cell subclass	RPL26 SELENOW FGFR2 RPL3 NPNT	8.73e-05	178	112	5	7b1e371272328d6b6c3994382d64281ffc737db2
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT\|bone_marrow / Manually curated celltypes from each tissue	PRSS35 EML4 LYAR MPZL3 CA2	8.73e-05	178	112	5	7ac71e245864be2e8daecf555ff68235bd05827c
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	CHL1 PRSS23 SYCP2 FGFR2 SLC4A4	8.96e-05	179	112	5	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_large-bowel / Manually curated celltypes from each tissue	PRSS35 EML4 LCK PLEK2 AHNAK	8.96e-05	179	112	5	6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EML4 LCK LYAR MPZL3 AHNAK	8.96e-05	179	112	5	b0585a8e596c3d8e434af943e65207fa5877600d
ToppCell	control-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RPL26 SELENOW LCK LYAR RPL3	9.20e-05	180	112	5	592fb72cc344efff1bd3376d9f28c79745c61469
Drug	AC1L1J0H	PRKD2 PIK3R3 SRC LCK CHUK PRKD3 SYK CTTN HCLS1	5.35e-07	197	111	9	CID000004813
Drug	lavendustin A	PRKD2 PIK3R3 SRC LCK ITPR3 PRKD3 FGFR2 CTTN	1.97e-06	171	111	8	CID000003894
Drug	oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA	DCAF8 SRC ST14 LIG3 TDRD3 PPIL2 ANKRD12 TRAM2	5.02e-06	194	111	8	971_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DCAF8 INHBA SRC NCOR1 LIG3 TDRD3 SYK SLC4A4	5.62e-06	197	111	8	6773_DN
Drug	NSC618487	PRKD2 INHBA INHBB PIK3R3 SRC GRIN2D LCK STT3B CHUK ITPR3 TGFB3 PRKD3 SYK DLD STK39 FGFR2	1.18e-05	933	111	16	CID000005279
Drug	AC1OAGFB	PRKD2 PIK3R3 SRC ZNF395 LCK ITPR3 PRKD3 PTPN11 SYTL4 MLST8 CTTN NSMAF	1.29e-05	539	111	12	CID006857345
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	PLK2 DCAF8 SRSF4 INHBB ITPR3 TDRD3 PPIL2	2.35e-05	174	111	7	6579_DN
Drug	lithium indium	SPIN2A SPIN2B	2.36e-05	2	111	2	CID011116062
Drug	scandium phosphate	SPIN2A SPIN2B	2.36e-05	2	111	2	CID006365269
Drug	rubidium nitrate	SPIN2A SPIN2B	2.36e-05	2	111	2	CID000025731
Drug	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	SRC LCK	2.36e-05	2	111	2	DB03023
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A	NDNF INHBA TGFB3 LIG3 SYK PPIL2 CTSZ	4.26e-05	191	111	7	3823_DN
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	INHBA TGFB3 LIG3 NUP210 SYK PPIL2 CTSZ	4.41e-05	192	111	7	7065_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	INHBB EYA3 NEB TDRD3 SYCP2 PPIL2 HCLS1	4.55e-05	193	111	7	6400_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	EML4 PIK3R3 MECP2 TDRD3 LOXL2 PPIL2 CTSZ	4.71e-05	194	111	7	3807_DN
Drug	PD173956	SRC LCK SYK	4.92e-05	15	111	3	CID005330524
Drug	Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A	VPS26C TGFB3 TDRD3 NUP210 SLC4A4 CTSZ DSE	5.02e-05	196	111	7	7143_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A	SYN3 SRC NEB MECP2 RAD50 AHNAK PPIL2	5.02e-05	196	111	7	4564_UP
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PIK3R3 VPS26C MECP2 TGFB3 PRKD3 PPIL2 TRAM2	5.02e-05	196	111	7	1696_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	PRKD2 NEB LIG3 TDRD3 SYK PPIL2 CTSZ	5.19e-05	197	111	7	3752_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	SRC PRKD3 NCOR1 LIG3 TDRD3 SYK PPIL2	5.19e-05	197	111	7	2641_DN
Drug	AC1L1G9T	PRKD2 PIK3R3 SRC LCK CHUK TGFB3 PRKD3 PTPN11 SYK CTTN	5.20e-05	433	111	10	CID000003591
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	DCAF8 SRC VPS26C PRKD3 PLEK2 ANKRD12 FGFR2	5.36e-05	198	111	7	7450_DN
Drug	Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A	DCAF8 PIK3R3 SRC VPS26C MECP2 LIG3 PPIL2	5.53e-05	199	111	7	6002_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A	DCAF8 VPS26C ST14 PLEK2 TDRD3 PPIL2 SLC4A4	5.71e-05	200	111	7	1368_UP
Drug	AG213	PRKD2 SRC LCK PRKD3 SYK	7.54e-05	89	111	5	CID005328803
Disease	double outlet right ventricle (implicated_via_orthology)	CFC1 CFC1B	4.05e-05	3	109	2	DOID:6406 (implicated_via_orthology)
Disease	dextro-looped transposition of the great arteries (implicated_via_orthology)	CFC1 CFC1B	8.07e-05	4	109	2	DOID:0060770 (implicated_via_orthology)
Disease	right atrial isomerism (implicated_via_orthology)	CFC1 CFC1B	8.07e-05	4	109	2	DOID:0060856 (implicated_via_orthology)
Disease	muscle measurement	PLK2 NEB	8.07e-05	4	109	2	EFO_0004515
Disease	Adenocarcinoma of lung (disorder)	PRKD2 PLK2 EML4 STK39 FGFR2 SLC4A4	1.20e-04	206	109	6	C0152013
Disease	Colorectal Carcinoma	CHL1 IRS4 ABCA13 SRC CSMD3 ABCA9 LIG3 PAN2 EXO1 DNAH8	2.80e-04	702	109	10	C0009402
Disease	blindness (implicated_via_orthology)	RPL26 RPL26L1	3.73e-04	8	109	2	DOID:1432 (implicated_via_orthology)
Disease	Cleft palate, isolated	CHUK TGFB3 FGFR2	5.07e-04	42	109	3	C1837218
Disease	FEV/FEC ratio	COL6A3 HTRA1 DCAF8 SYN3 EML4 TUT7 PRSS23 NEB SYTL4 FGFR2 CTTN RPL3 NPNT	6.07e-04	1228	109	13	EFO_0004713
Disease	visceral heterotaxy (is_implicated_in)	CFC1 CFC1B	8.71e-04	12	109	2	DOID:0050545 (is_implicated_in)
Disease	phenylacetylglutamine measurement	SRC SYCP2	8.71e-04	12	109	2	EFO_0021013
Disease	tetralogy of Fallot (is_implicated_in)	PTPN11 CFC1B	1.03e-03	13	109	2	DOID:6419 (is_implicated_in)
Disease	Skin Abnormalities	CHUK FGFR2	1.03e-03	13	109	2	C0037268
Disease	chronic obstructive pulmonary disease	COL6A3 HTRA1 SYN3 EML4 TM9SF4 PRSS23 CTTN VARS1 NPNT	1.04e-03	688	109	9	EFO_0000341
Disease	colon cancer (is_marker_for)	SRC CHUK TGFB3	1.37e-03	59	109	3	DOID:219 (is_marker_for)
Disease	Intellectual Disability	CHL1 GRIN2D MECP2 STT3B ZNF462 FGFR2 CA2	1.38e-03	447	109	7	C3714756
Disease	carcinoma (implicated_via_orthology)	SRC TSG101 LCK	1.73e-03	64	109	3	DOID:305 (implicated_via_orthology)
Disease	Multiple congenital anomalies	CHUK FGFR2	1.77e-03	17	109	2	C0000772
Disease	Limb Deformities, Congenital	CHUK FGFR2	1.77e-03	17	109	2	C0206762
Disease	age-related macular degeneration, COVID-19	HTRA1 SYN3 RPL3	2.15e-03	69	109	3	EFO_0001365, MONDO_0100096
Disease	photoreceptor cell layer thickness measurement	HTRA1 KIF14 STK39 FGFR2	2.25e-03	148	109	4	EFO_0803370
Disease	Liver Cirrhosis, Experimental	SELENOW MDH1 ST14 TGFB3 LOXL2 AHNAK SPIN2A SLC4A4 CTSZ	2.32e-03	774	109	9	C0023893
Disease	Craniosynostosis	ZNF462 FGFR2	2.46e-03	20	109	2	C0010278
Disease	disease of metabolism (implicated_via_orthology)	PTPN11 DLD	2.71e-03	21	109	2	DOID:0014667 (implicated_via_orthology)
Disease	squamous cell lung carcinoma	DCAF8 NEB CHUK VARS1	3.33e-03	165	109	4	EFO_0000708
Disease	Cleft Palate	CHUK TGFB3 FGFR2	3.39e-03	81	109	3	C0008925

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKTVVHQGDGKLILY	ERICH6B	466	Q5W0A0
YKMVKHRGDKGNEEN	B4GALT3	286	O60512
VFFRKHTQAEGKKLG	ACYP1	21	P07311
GDVLKIYDGKDKTTH	CSMD3	1291	Q7Z407
KDGKGARYNLAIEEH	CTSZ	281	Q9UBR2
GDYKKKAHSQLRISG	ABCA9	1046	Q8IUA7
QHIKNRFGDGYTVKV	ABCA13	4941	Q86UQ4
DVDLHVKGTKVKGEY	AHNAK	701	Q09666
EKYITGRVLEAGEKH	ABLIM2	216	Q6H8Q1
YQREKHNGGREEVTK	CFC1B	26	P0CG36
TKKEYVVSGEHKQKG	ANKRD12	456	Q6UB98
YQREKHNGGREEVTK	CFC1	26	P0CG37
KEIQVKNHIRKDGDY	ADAMTS20	1716	P59510
AIRKLHVGKVGENGY	INHBA	86	P08476
VKKKGYVRLHTNKGD	PPIL2	276	Q13356
GRQKGYEEEIIHFKK	RAD50	1076	Q92878
KVREIYDKHKSNVGG	EYA3	421	Q99504
TENKKVHGDVVKYGS	ITPR3	106	Q14573
RNEVRTHVGSYKGKK	GRSF1	326	Q12849
GKGAAYAHAEESIKK	HACL1	221	Q9UJ83
GTSIHYKVQKIRQGK	NUP210	256	Q8TEM1
KEFKQEHRIGGYKVR	FGFR2	196	P21802
ESFHKVLKGLYEKGR	PAN2	1161	Q504Q3
SKNKGVPKRVYELHG	KIF14	1616	Q15058
NRGGKYSVKEKEDLH	CHL1	1106	O00533
DIKSVVFKGEKRRGH	NPNT	531	Q6UXI9
GKVLHYRIDKDKTGK	SYK	211	P43405
EEYAGHGQATKRKKR	GARIN4	96	Q8IYT1
HKIIDLGYAKDVDQG	CHUK	161	O15111
KVRVKVYFQEQGHGD	INHBB	196	P09529
AGQKRKHSEGRVEVY	LOXL2	61	Q9Y4K0
NHAKVKLQGKEVGVY	MDH1	196	P40925
TGEIKREYGGHQKAV	MLST8	301	Q9BVC4
EKDGHVERKSKNGLY	NUDT9	126	Q9BW91
KRYKGHRNNATVKGV	DCAF8	426	Q5TAQ9
YTGKVGKQSEQRKHV	DNAH8	786	Q96JB1
YGGKHRKTGRDVAVK	PRKD2	566	Q9BZL6
YGGKHRKTGRDVAIK	PRKD3	591	O94806
GGHSVKYQSKVVKTR	NDNF	551	Q8TB73
ADAHVRGYVGEKIKL	MPZL3	36	Q6UWV2
TYEKHKNGGLIKGRF	DSE	866	Q9UL01
EVVKHYKIRNLDNGG	LCK	176	P06239
EEQKSKRKGHEYTNI	PTPN11	531	Q06124
EIKYDGERVQVHKNG	LIG3	506	P49916
AGSVDHKGKQRKVVD	OSTN	96	P61366
KGGNNKLIKIYHRDG	PIK3R3	106	Q92569
HRVKVELKNGATYEA	HTRA1	226	Q92743
QVLDYVKEGGHKKVQ	FARP1	346	Q9Y4F1
INKVVYKGGRHANTK	COL6A3	1706	P12111
KVVHVNGYGKITGKN	DLD	146	P09622
NGEVKEIRKEEYGHN	CFHR5	216	Q9BXR6
QVKDNRHVYEGKDGA	FMNL2	1036	Q96PY5
KGYEGKTHKGDIKQQ	LYAR	61	Q9NX58
KEHNVVAPYKIERGK	NSMAF	116	Q92636
KGVYQISKQIKAHDG	EML4	496	Q9HC35
GEVFKARHRKTGQKV	CDK9	31	P50750
YRVGHKGKVDLKCVG	MIB2	211	Q96AX9
SRYDGINHVIVKQGK	PGBD3	546	Q8N328
KDDEVQVVRGHYKGQ	RPL26L1	51	Q9UNX3
GEEVCKRGYLRKQKH	IRS4	76	O14654
AAEKYKHRGEGERKD	MECP2	446	P51608
SGHKNTRDDKKEKGY	GARIN3	471	Q8TC56
KEKGYSNVRGKRHGS	GARIN3	481	Q8TC56
IKRKGAKRGSQHYSD	SYTL4	46	Q96C24
EEKGDRIYHQLKKLG	VARS1	421	P26640
KYFHGKKVNGEIEIR	SYN3	106	O14994
NVKHYKIRKLDSGGF	SRC	201	P12931
HKGRKNEGVIEFVSY	SRSF4	136	Q08170
GEVRLVQKKDTGHVY	STK38	101	Q15208
KEKSTKSEGKHEGVY	TDRD3	176	Q9H7E2
KSEGKHEGVYRELVD	TDRD3	181	Q9H7E2
LIHSKKKGDGYVDTE	SELENOW	56	P63302
RCIHVYKKNGVGKVG	MRPL14	56	Q6P1L8
KGEVEKHTSQKDYSR	HCLS1	141	P14317
GKYHKQIKIEENATG	MITD1	86	Q8WV92
HRTEINKKIYKIGQG	RPL3	276	P39023
CIHDGKTYVKGTQKL	PRSS23	176	O95084
REEAASKGHVIYEGK	NCOR1	1201	O75376
RHVTYVVAKKGVGRK	FTSJ3	796	Q8IY81
GKHVEYTKEDGSKRI	SPIN2A	211	Q99865
NKGEEVKRIEFKHGG	OSCP1	221	Q8WVF1
KEASEPIHVRKYKGQ	EXO1	11	Q9UQ84
DGQGSEHTVDKKKYA	CA2	101	P00918
TIKTGKHVDANGKIY	TSG101	96	Q99816
KGSASVDEYKVHKEG	ZNF431	146	Q8TF32
GTVVKQGYLAKQGHK	PLEK2	246	Q9NYT0
EHKGKQICKYFLEGR	ZC3H6	271	P61129
KKEKDVQFEHGYRLG	TM9SF4	156	Q92544
KHESQKDYVKGFGGK	CTTN	221	Q14247
YDKAGKVRKHATEQE	STT3B	511	Q8TCJ2
KDDEVQVVRGHYKGQ	RPL26	51	P61254
GKHVEYTKEDGSKRI	SPIN2B	211	Q9BPZ2
DHNSEGTGKVKYKKE	SYCP2	661	Q9BX26
GTGKVKYKKEQTDHI	SYCP2	666	Q9BX26
LIKRESGYHENGVVK	TRAM2	341	Q15035
VHDGKDYVKGSKKLR	PRSS35	171	Q8N3Z0
KYNSRHEKVNGLEEG	ST14	21	Q9Y5Y6
GEAKKCRKVYGIEHR	ZNF395	481	Q9H8N7
VKIGVDYFKVGRHVD	TTC14	311	Q96N46
IHVGDKSYKSNRGGK	ZNF226	776	Q9NYT6
NYKGHGLSKGKEREQ	TTLL9	26	Q3SXZ7
KTHEKEKSYALGGAR	ZSCAN18	461	Q8TBC5
GNRTVKGVLIHYQKK	ZNF462	1201	Q96JM2
VEHEGVLKGQKSYRC	ZKSCAN7	371	Q9P0L1
KGKAKSYHEIGRAIA	SLC4A4	331	Q9Y6R1
LFGGKKDKARYIDTH	PLK2	371	Q9NYY3
VYHPETGRKNEKEKV	TUT7	741	Q5VYS8
KYIVNRGEHKNGVLE	STK39	151	Q9UEW8
DSKKHTGYVGLKNQG	USP7	206	Q93009
RNGVKEKHGSDYSKD	SULF2	176	Q8IWU5
DFGHIKKKRVEAIRG	TGFB3	31	P10600
DIKIKRANKVYHAGE	VPS26C	6	O14972
HTGEKLYQRKEFGKT	ZNF283	621	Q8N7M2
KKAYEQAKGKHIGFR	NEB	1821	P20929
KQKGHYLAGKVIGEF	NEB	4501	P20929
YLVTNGKHGKKIDGV	GRIN2D	506	O15399